1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Comprehensive Partnerships to Advance Cancer Health (CPACH) is a grant from the National Institutes of Health that funds long-term, mutually beneficial partnerships between Research-Limited Institutions (RLIs) and NCI-designated Cancer Centers to advance cancer research and reduce disparities in cancer outcomes.
This U54 cooperative agreement supports a stronger national cancer program by addressing health drivers that contribute to differences in cancer outcomes across all populations, with emphasis on cancer outreach and engagement. Award amounts reach up to $850,000.
Eligible applicants include nonprofits with and without 501(c)(3) status, institutions of higher education, tribal governments, faith-based organizations, and other qualifying entities.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional) Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional) Agency: National Institutes of Health Assistance Listings: 93. 393 -- Cancer Cause and Prevention Research 93. 394 -- Cancer Detection and Diagnosis Research 93.
395 -- Cancer Treatment Research 93. 396 -- Cancer Biology Research 93. 398 -- Cancer Research Manpower 93.
397 -- Cancer Centers Support Grants Last Updated: August 28, 2025 View version history on Grants. gov This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health (CPACH) Program. The CPACH Program develops and maintains comprehensive, long-term, mutually beneficial partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs).
The program aims to achieve a stronger national cancer program and addresses challenges in cancer research, including a focus on advancing research on health drivers that contribute to differences in cancer outcomes across all populations, as well as cancer outreach and engagement.
For-profit organizations other than small businesses Private institutions of higher education Independent school districts Public and state institutions of higher education Special district governments Federally recognized Native American tribal governments City or township governments Nonprofits non-higher education without 501(c)(3) Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Other Eligible ApplicantsEligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Grantor contact information Sandra San Miguel-Majors, DrPH, MS No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity :
According to the current listing, eligibility includes: Nonprofits, including those without 501(c)(3) status, and other organizations. Confirm the full requirements in the official notice before applying.
The current listing shows $850,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
After an authorization lapse froze new SBIR/STTR awards for five months, NIH reopens its submission window on August 5, 2026, with a first standard deadline of September 8. Phase I awards run to $323,090, Phase II to $2,153,927, with published waiver topics reaching $700,000 and $3 million — and a new Phase IIB Strategic Breakthrough lane up to $30 million. Here is how the restarted omnibus is structured, why applying early matters more than usual this cycle, and how to position a life-science startup to win.
Read articleNIH has awarded 74% fewer new grants than its 2021-2024 average and is roughly $1 billion behind its normal timeline, but the FY2026 money still has to go out the door before the fiscal year ends. Here is why a year-end obligation cliff is coming, who is positioned to catch it, and how applicants should prepare for a compressed Q4 award rush.
Read articleNew NIH awards have fallen 34% in 2026, NSF is running months behind, and a proposed OMB rule would let political appointees terminate grants mid-stream. The funding environment for academic research has structurally changed. Here is a clear-eyed diversification strategy for PIs, research offices, and institutions that cannot wait for the political fight to resolve.
Read article